Diligence memo · auto-generated · as of July 2, 2026
Medracon, Inc.
Medracon, Inc. looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Medracon, Inc. operates in Pharmaceuticals, based in OAK BROOK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Medracon, Inc. has raised $6.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $6.0M on —.
Valuation (modeled)modeled
Provath models Medracon, Inc. at approximately $13M (range $6.9M–$17M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.09× the median modeled value of Series A Pharmaceuticals companies (418 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
No dated round to assess.
Comparablesmixed
Capital scale ranks ahead of 45% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 21% of those peers.
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.